APPLICATION
ANDA210019
TYPE
ANDA
ORIGINAL APPROVAL
2019-09-13
LATEST ACTION
2024-03-06
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription
Products
IVERMECTINPrescription
IVERMECTIN 1% · CREAM · TOPICAL
Approval history
2024-03-06Labeling · Supplement 3 · standardAP
2020-07-09Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.